NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) — Kenneth Research has an in-depth market report on the “Global Prefilled Syringes Market“ for the forecast period i.e. 2023–2033, which includes the following factors:
- Market growth over the forecast period
- Detailed regional summary
- market segmentation
- growth accelerator
- challenges
- Key market players and their detailed profiling
Size of the global prefilled syringe market
The global prefilled syringe market is expected to reach around USD 16,100 million by 2033, growing at a CAGR of ~12% during the forecast period. Additionally, the market generated approximately $5,900 million in revenue in 2022. The market is mainly driven by the increase in HIV and hepatitis infection rates. In 2019, 296 million people worldwide had hepatitis B and 58 million had hepatitis C, according to the Centers for Disease Control and Prevention (CDC).
Get a sample PDF of this report @ https://www.kennethresearch.com/sample-request-10352443
The demand for pre-filled syringes is increasing as there is a greater risk of infection from needles. Around 900 healthy children under the age of 12 in Pakistan received HIV-infected needles from a doctor and were added to the list of confirmed HIV cases. In addition, the prefilled syringe market is expected to expand due to the increase in chronic diseases such as diabetes, cardiovascular problems, arthritis, and others. According to statistics from the World Health Organization (WHO), cardiovascular diseases claimed the lives of almost 18 million people.
Global Prefilled Syringes Market: Key Insights
- The Europe region generates the largest share of sales
- The Diabetes segment to influence sales chart
- The single chamber segment retains a significant presence in the market
Increasing HIV and Hepatitis B cases and increasing biologic drug adoption to boost market growth
The self-filling needles used in people living with HIV and hepatitis…
